Company Filing History:
Years Active: 2016-2017
Title: The Innovative Contributions of Stuart Denham Shumway
Introduction
Stuart Denham Shumway is a notable inventor based in Franklin, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 2 patents, Shumway's work focuses on the development of compositions and methods aimed at treating various types of cancer.
Latest Patents
Shumway's latest patents include groundbreaking methods for treating WEE1 kinase associated cancers. One patent details the administration of a WEE1 inhibitor, specifically WEE1-1 or WEE1-2, to patients with low expression levels of PKMYT1. Another patent provides a method for treating cancers such as breast cancer, melanoma, colorectal cancer, non-small cell lung cancer, and ovarian cancer. This method involves administering a combination of a WEE1 inhibitor, like MK-1775 or MK-3652, along with a CHK1 inhibitor, such as MK-8776 or SCH900444.
Career Highlights
Stuart Denham Shumway is currently associated with Merck Sharp & Dohme Corporation, where he continues to advance his research in cancer treatment. His work has the potential to significantly impact the lives of patients suffering from various forms of cancer.
Collaborations
Shumway has collaborated with esteemed colleagues, including Carlo Toniatti and Brian Scott Roberts, to further enhance the effectiveness of his research and innovations.
Conclusion
Stuart Denham Shumway's contributions to cancer treatment through his innovative patents highlight his dedication to improving patient outcomes. His work exemplifies the importance of research and innovation in the medical field.